Susquehanna International Group
LNAI

Susquehanna International Group’s Lunai Bioworks LNAI Stock Holding History

Susquehanna International Group’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-201
Closed -$7.73K – 13039
2024
Q3 		$7.73K Buy
+201
New +$13.9K ﹤0.01% 11735
2024
Q2 		– Sell
-156
Closed -$33.1K – 13036
2024
Q1 		$33.1K Buy
+156
New +$42.1K ﹤0.01% 11687

Other funds holding LNAI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NMC
Nine Masts Capital Central, Hong Kong $995M AUM 22.79% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group's LNAI Position: Q3 2025 in Review

Susquehanna International Group sold out of Lunai Bioworks (LNAI) in Q3 2025, closing a stake of 3,279 shares — an estimated $63.2K sold.

Susquehanna International Group first reported a position in LNAI in Q2 2019 and held it in 13 quarters. The position peaked at $472K in Q1 2024. 20 funds tracked by Wall St. Rank hold LNAI as of Q3 2025.

  • Susquehanna International Group reported no remaining Lunai Bioworks position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 3,279 Lunai Bioworks shares in Q3 2025, an estimated $63.2K.
  • Susquehanna International Group first reported a position in Lunai Bioworks in Q2 2019 and held it in 13 quarters.
  • Susquehanna International Group's Lunai Bioworks position peaked at $472K in Q1 2024.
  • 20 funds tracked by Wall St. Rank held Lunai Bioworks as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.